A team of researchers in Kansai is set to begin clinical trials next month to develop medicine to help grow teeth.
The researchers, including from Kitano Hospital and Kyoto University Hospital, will conduct trials for teething medicine, aimed at treating people with congenital anodontia who are born with few teeth.
To check its safety, the experimental drug will first be administered to adult men who have lost back teeth, before it is tested on children with congenital anodontia. The team aims to put the treatment into practical use in around 2030.
Because /hobthrob is incorrect. This medication will not and cannot be used to regrow teeth in people that don’t have the genetic disorder “congenital anodontia”. The drug can only help that >1% with the disorder.